Chloe L. Peach-Thompson

Adelaide, SA, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Ultraprecision therapy for type 1 vs type 2 CALR+ MPN by dual epitope targeting that restores ruxolitinib sensitivity.

Ultraprecision therapy for type 1 vs type 2 CALR+ MPN by dual epitope targeting that restores ruxolitinib sensitivity.

Journal: Blood
Published: December 09, 2024

IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation.

IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation.

Journal: Blood
Published: December 18, 2023

Author Correction: Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia.

Author Correction: Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia.

Journal: Nature communications
Published: July 15, 2022

Thrombopoietin-independent Megakaryocyte Differentiation of Hematopoietic Progenitor Cells from Patients with Myeloproliferative Neoplasms.

Thrombopoietin-independent Megakaryocyte Differentiation of Hematopoietic Progenitor Cells from Patients with Myeloproliferative Neoplasms.

Journal: Bio-protocol
Published: June 14, 2022

A senescence stress secretome is a hallmark of therapy-related myeloid neoplasm stromal tissue occurring soon after cytotoxic exposure.

A senescence stress secretome is a hallmark of therapy-related myeloid neoplasm stromal tissue occurring soon after cytotoxic exposure.

Journal: Leukemia
Published: December 16, 2021

Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia.

Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia.

Journal: Nature communications
Published: October 11, 2021

Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia.

Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia.

Journal: Blood
Published: July 09, 2021

Targeting human CALR-mutated MPN progenitors with a neoepitope-directed monoclonal antibody.

Targeting human CALR-mutated MPN progenitors with a neoepitope-directed monoclonal antibody.

Journal: EMBO reports
Published: June 10, 2021

Neonatal heel prick mass spectrometry identifies metabolic predictors of AML latency.

Neonatal heel prick mass spectrometry identifies metabolic predictors of AML latency.

Journal: Leukemia research
Published: May 26, 2021

Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability.

Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability.

Journal: Cancer discovery
Published: March 02, 2021
Showing 1-10 of 10

Last Updated: 09/26/2026